Evidence map›Paper›PMID 37564369›Full record

ArticleFrontiers in neuroscience2023

Deep intracochlear injection of triamcinolone-acetonide with an inner ear catheter in patients with residual hearing.

Nils K Prenzler, Rolf Salcher, Thomas Lenarz, Lutz Gaertner, Anke Lesinski-Schiedat, Athanasia Warnecke

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Angular Insertion Depth for Cochlear Implantation: A Comparative Analysis on Precision of CT, MRI, and x-Ray.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Drug selection for inner ear therapy.Frontiers in pharmacology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nils K PrenzlerDepartment of Otorhinolaryngology, Head and Neck Surgery, Hannover Medical School, Hanover, Germany.
Rolf SalcherDepartment of Otorhinolaryngology, Head and Neck Surgery, Hannover Medical School, Hanover, Germany.
Thomas LenarzDepartment of Otorhinolaryngology, Head and Neck Surgery, Hannover Medical School, Hanover, Germany.
Lutz GaertnerDepartment of Otorhinolaryngology, Head and Neck Surgery, Hannover Medical School, Hanover, Germany.
Anke Lesinski-SchiedatDepartment of Otorhinolaryngology, Head and Neck Surgery, Hannover Medical School, Hanover, Germany.
Athanasia WarneckeDepartment of Otorhinolaryngology, Head and Neck Surgery, Hannover Medical School, Hanover, Germany.
Medizinische Hochschule Hannover · DEHearing4all · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In a previous study, an inner ear catheter was used to deliver low- and high-dose steroids into the cochlea prior to cochlear implant electrode insertion. With this approach, more apical regions of the cochlea could be reached and a reduction of electrode impedances in the short term was achieved in cochlear implant recipients. Whether intracochlear application of drugs via the catheter is a safe method also for patients with residual hearing has not been investigated hitherto. The aim of the present study was therefore to investigate the effect of intracochlear triamcinolone application in cochlear implant recipients with residual hearing. Patients and methods: Patients with residual hearing were administered triamcinolone-acetonide (4 mg/ml; Results: The median hearing loss after implantation (125-1,500 Hz) was 20.6 dB. Four patients (40%) showed a median hearing loss of less than 15 dB, three patients (30%) between 15 and 30 dB and three patients (30%) more than 30 dB. The median hearing loss was similar to the results obtained from our previous study showing a median hearing loss of 24 dB when using FLEX28 electrode arrays. Conclusion: No difference in residual hearing loss was found when comparing application of triamcinolone-acetonide using an inner ear catheter prior to the insertion of a FLEX28 electrode array to the use of the FLEX28 electrode array without the catheter. Thus, we conclude that application of drugs to the cochlea with an inner ear catheter could be a feasible approach in patients with residual hearing.

Indexed as

cathetercochlear implantdrug deliveryhearing preservationimpedancesinner earsteroids

Identifiers

PMID37564369
PMCPMC10410142
OpenAlexW4385281724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.